Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The interaction between reactive oxygen species (ROS) and lipid membranes is a fundamental biochemical process that, when uncontrolled, leads to lipid peroxidation and cellular damage. ROS, such as the hydroxyl radical and superoxide, can initiate a chain reaction by abstracting hydrogen atoms from polyunsaturated fatty acids (PUFAs) within the phospholipid bilayer, resulting in the formation of lipid hydroperoxides and reactive aldehydes like malondialdehyde (MDA) and 4-hydroxynonenal (4-HNE) (Ayala et al., 2014; Yin et al., 2011). This process compromises membrane integrity and fluidity, eventually leading to various forms of cell death, most notably ferroptosis (Stockwell et al., 2017). Pathologically, this interaction is a key driver in neurodegenerative diseases, cardiovascular disorders, and ischemia-reperfusion injury (Gaschler & Stockwell, 2017). Therapeutic strategies targeting this process include the use of radical-trapping antioxidants (RTAs) like Ferrostatin-1 and Liproxstatin-1, which terminate the peroxidation chain, as well as iron chelators that prevent the generation of initiating radicals. Maintaining the balance between ROS production and antioxidant defense is crucial, as ROS also serve as important signaling molecules in normal physiology.
Radical scavenging and inhibition of the lipid peroxidation chain reaction through hydrogen atom transfer or transition metal chelation.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Reactive oxygen species and lipid membranes.